Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Sean D. Sullivan, PhD, MSc, RPh

Articles by Sean D. Sullivan, PhD, MSc, RPh

Diagnosis and Management of TRK Fusion Cancer

ByShivaani Kummar, MD, FACP,Antoine Italiano, MD, PhD,Marcia S. Brose, MD, PhD,Josh J. Carlson, PhD, MPH,Sean D. Sullivan, PhD, MSc, RPh,Ulrik Lassen, MD, PhD,Noah Federman, MD

January 11th 2022

Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer

ByJosh J. Carlson, PhD, MPH,Antoine Italiano, MD, PhD,Marcia S. Brose, MD, PhD,Noah Federman, MD,Ulrik Lassen, MD, PhD,Shivaani Kummar, MD, FACP,Sean D. Sullivan, PhD, MSc, RPh

January 11th 2022

Latest Updated Articles

Diagnosis and Management of TRK Fusion Cancer
January 11th 2022
Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer
January 11th 2022

Trending on AJMC

FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301

Cancer’s Hidden Wound: Trauma From Diagnosis Through Survivorship

Odronextamab Plus CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Matthew Matasar, MD

New French Psoriasis Guidelines Add Biologics, Comorbidity Guidance to Algorithm

New Data Support Pimicotinib as Durable for Rare Tenosynovial Giant Cell Tumor